NDC 0469-1125 – Xtandi

Enzalutamide 40 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC0469-1125

Product details

Brand name
Xtandi
Generic name
Enzalutamide
Labeler
Astellas Pharma US, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA203415
Marketed since
August 31, 2012
Listing expires
December 31, 2027
Pharmacologic class
Androgen Receptor Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Xtandi →

Package NDC codes (1)

Package NDCDescriptionSince
0469-1125-56 sample56 CAPSULE in 1 BLISTER PACK (0469-1125-56)Aug 31, 2012

Other Xtandi products